spot_img
HomeMalaysiaIJN SUCCESSFULLY PERFORMS MITRACLIP AND TRICLIP PROCEDURE ON 100TH PATIENT

IJN SUCCESSFULLY PERFORMS MITRACLIP AND TRICLIP PROCEDURE ON 100TH PATIENT

spot_img

KUALA LUMPUR, January 22, 2024:

 Institute Jantung Negara (IJN) recently commemorated a significant achievement by successfully performing 100 complex heart procedures utilizing the innovative MitraClip/ TriClip device to treat Mitral/ Tricuspid regurgitation. IJN is the fourth hospital in the region to reach this milestone, solidifying the centre’s commitment to advancing cutting-edge cardiovascular care.

The 100th TEER procedure was carried out last Friday (Jan 19) by a team of cardiologists led by Dato’ Dr Azmee Mohd Ghazi, Clinical Director of Heart Failure and Heart Transplant at IJN.

“This milestone speaks volumes about our team’s skill and dedication to improving outcomes for patients with Mitral/ Tricuspid valve regurgitation,” said Dr. Azmee. ‘l Our expertise in this procedure has been honed by over a decade of experience, and we are immensely proud to have positively impacted the lives of 100 patients. This milestone reflects our drive to continue delivering exceptional cardiac treatments.”

IJN had previously set a precedent by being the first in Malaysia to introduce the MitraClip procedure. The pioneering case was performed in December 2011 by leading Malaysian Cardiologist Tan Sri Dato’ Seri Dr Robaayah Zambahari, as well as Senior Consultant Cardiologists Datuk Dr Mohd Nasir Muda and Datuk Dr Amin Ariff Nuruddin. Since then, the programme has continued under Dr Amin Ariffs mentorship.

Mitral/ Tricuspid regurgitation is a common type of heart valve disease. It occurs when the Mitral/ Tricuspid valve fails to close properly, causing blood to teak backwards into the heart. If left untreated, the condition can cause progressive heart enlargement, and ultimately lead to heart failure.

The conventional way to treat severe Mitral/ Tricuspid regurgitation is surgical intervention to either repair or replace the faulty Mitral/ Tricuspid valve. As this approach often involves open-heart surgery, such surgical intervention can be a risky option particularly for patients with comorbid conditions or who are at an advanced age.

The MitraClip/ TriClip — a small device designed to narrow the Mitral/ Tricuspid valve opening — offers an alternative to open-heart surgery. The device is delivered to the heart via a catheter, through a small incision in the leg vein. Typically taking around two to three hours to complete, the minimally invasive procedure allows for quicker recovery times and mitigates the risks of traditional surgery.

As IJN celebrates this latest accomplishment, the Centre remains steadfast in its mission to further expand access to cutting-edge cardiac treatments, while upholding its reputation for excellence and innovation in healthcare.

spot_img
spot_img

Stay Connected

203,149FansLike
2,137FollowersFollow
1,156FollowersFollow

Must Read

spot_img

Related News

- Advertisement -spot_img

LEAVE A REPLY

Please enter your comment!
Please enter your name here